Previous studies have shown that cholesterol in the TME can induce CD8+ T cell functional exhaustion, and that inhibiting cholesterol metabolism in CD8+ T cells can restore their anti-tumor activities, presenting a novel strategy to enhance T cell-based cancer immunotherapy [87]. The gene discussed is CD8A; the disease is cancer.